Oak Associates’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Oak Associates’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,315	Closed	-$287K	–	164
2017 Q4	$287K	Hold	5,315	–	–	0.02%	151
2017 Q3	$303K	Hold	5,315	–	–	0.02%	155
2017 Q2	$320K	Hold	5,315	–	–	0.02%	154
2017 Q1	$289K	Buy	+5,315	New	+$262K	0.02%	157

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Oak Associates's BIVV Position: Q1 2018 in Review

Oak Associates sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,315 shares — an estimated $287K sold.

Oak Associates first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $320K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Oak Associates reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Oak Associates sold 5,315 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $287K.
Oak Associates first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Oak Associates's Bioverativ Inc. Common Stock position peaked at $320K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Oak Associates's 13F filing for Q1 2018, filed 14 May 2018.